Floatz logo

ji-101

Neuroendocrine

University of UtahPhase 1/2Dormant
CCC
48/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
33/ 100
Competitive Position
95/ 100

Competitive context

62 Active assets in the Neuroendocrine cohort.

Asset / SponsorPhaseRating
Irinotecan
First Affiliated Hospital Xi'an Jiaotong University
Phase 4BB
Bms-907351
Fox Chase Cancer Center
Phase 3BB
Eloxatin
ITM Solucin GmbH
Phase 3BB
FLUOROURACILUM
ITM Solucin GmbH
Phase 3BB
Pasireotide
RECORDATI GROUP
Phase 4BB

View all 50 →

Same molecule, other indications

ji-101 is also rated in:

cancerDormant
CC
Indicative ·
42 / 100
View asset →
colon carcinomaDormant
CC
Indicative ·
41 / 100
View asset →
ovarian cancerDormant
CC
Indicative ·
40 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →